T002
This study evaluated different dosages of a monoclonal antibody given in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018.
T003
/in Completed StudiesThis study is assessing the use of an infusion of three antibodies as an alternative treatment for people living with HIV.
HTX1002
/in Completed StudiesThis study is assessing a therapeutic HIV vaccine as an alternative treatment for people living with HIV. This trial completed enrollment in January 2020 and is ongoing.
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
CVVR Clinical Trials Unit
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu